Research Article
Validation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity Questionnaire for the Latin American Population
Table 4
Comparison of peripheral neuropathy according to cancer type (
).
| | Breast | Colorectal | Hematologic | Gastric | Gynaecological | Other |
| Physical well-being, PWB (0–28) | 21.9 (5.7) | 21.0 (5.0) | 17.5 (5.2) | 21.0 (4.7) | 11.3 (12.3) | 20. 7 (6.7) | Social/family well-being, SWB (0–28) | 20.5 (5.6) | 16.9 (6.8) | 16.8 (6.2) | 29.6 (6.2) | 20.0 (4.0) | 19.8 (7.4) | Emotional well-being, EWB (0–24) | 17.6 (3.8) | 17.7 (4.6) | 15.6 (3.9) | 20.4 (4.9) | 11.3 (4.0) | 17.9 (5.6) | Functional well-being, FWB (0–28) | 21.6 (3.5) | 17.9 (6.4) | 15.7 (6.1) | 20.0 (7.2) | 16.7 (7.1) | 18.8 (3.8) | Neurotoxicity, NtxS (0–44) | 32.0 (8.1) | 30.3 (8.6) | 29.1 (7.4) | 32.3 (5.3) | 27.7 (13.4) | 33.4 (6.3) | FACT/GOG-Ntx total score (0–152) | 113.8 (18.5) | 103.9 (25.6) | 94.7 (21.3) | 114.3 (21.3) | 87.0 (35.3) | 110.6 (24.3) | FACT-G total score (0–108) | 81.8 (12.4) | 73.5 (19.5) | 65.6 (16.2) | 82.0 (17.2) | 59.3 (21.9) | 77.1 (18.6) | FACT/GOG-Ntx TOI (0–100) | 75.6 (13.7) | 69.2 (17.1) | 62.3 (15.0) | 73.3 (12.3) | 55.7 (30.7) | 72.9 (14.4) |
|
|
Abbreviations: . . Values are expressed as mean (standard deviation). |